Drug Therapy

  • In reply: Opioid therapy and sleep apnea (June 2016)
    Marissa C. Galicia-Castillo, MD
    Cleveland Clinic Journal of Medicine February 2017, 84 (2) 94; DOI: https://doi.org/10.3949/ccjm.84c.02002
  • Pharmacotherapy for obesity: What you need to know
    Sophie Bersoux, MD, MPH, Tina H. Byun, MD, Swarna S. Chaliki, MD and Kenneth G. Poole, MD, MBA
    Cleveland Clinic Journal of Medicine December 2017, 84 (12) 951-958; DOI: https://doi.org/10.3949/ccjm.84a.16094

    Weight-loss drugs are not magic pills, but they can help when used along with diet, exercise, and other lifestyle changes.

  • It’s time to consider pharmacotherapy for obesity
    Derrick C. Cetin, DO
    Cleveland Clinic Journal of Medicine December 2017, 84 (12) 959-960; DOI: https://doi.org/10.3949/ccjm.84a.17077

    Consider using chronic weight-loss medications as adjunctive therapy if lifestyle and behavioral strategies are ineffective.

  • Serotonin syndrome: Preventing, recognizing, and treating it
    Robert Z. Wang, MD, Vishal Vashistha, MD, Sukhdeep Kaur, MBBS and Nathan W. Houchens, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11) 810-816; DOI: https://doi.org/10.3949/ccjm.83a.15129

    Serotonin syndrome can be easily overlooked, misdiagnosed, or exacerbated. Early recognition is critical.

  • Left ventricular thrombosis can still complicate acute myocardial infarction
    Left ventricular thrombosis can still complicate acute myocardial infarction
    Muhammad Umer Tariq, MD, Ali M. Tariq, MD, Carmela D. Tan, MD, E. Rene Rodriguez, MD and Venu Menon, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11) 819-826; DOI: https://doi.org/10.3949/ccjm.83a.14078

    Despite revascularization, the next day the patient had an ejection fraction of 35% and a mass in the left ventricle.

  • Breaking the pain contract: A better controlled-substance agreement for patients on chronic opioid therapy
    Daniel G. Tobin, MD, FACP, Kristine Keough Forte, MS, MA, DBioethics and Summer Johnson McGee, PhD, CPH
    Cleveland Clinic Journal of Medicine November 2016, 83 (11) 827-835; DOI: https://doi.org/10.3949/ccjm.83a.15172

    Common limitations of current pain treatment “contracts,” and strategies to improve them.

  • Bioresorbable stents: The future of interventional cardiology?
    Stephen G. Ellis, MD and Haris Riaz, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11 suppl 2) S18-S23; DOI: https://doi.org/10.3949/ccjm.83.s2.03
  • PCSK9 inhibition: A promise fulfilled?
    Khendi White, MD, Chaitra Mohan, MD and Michael Rocco, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11 suppl 2) S36-S44; DOI: https://doi.org/10.3949/ccjm.83.s2.05
  • The ABCs of managing systolic heart failure: Past, present, and future
    Ike S. Okwuosa, MD, Oluseyi Princewill, MD, MPH, Chiemeke Nwabueze, MD, Lena Mathews, MD, Steven Hsu, MD, Nisha A. Gilotra, MD, Sabra Lewsey, MD, MPH, Roger S. Blumenthal, MD and Stuart D. Russell, MD
    Cleveland Clinic Journal of Medicine October 2016, 83 (10) 753-765; DOI: https://doi.org/10.3949/ccjm.83a.16006

    Digitalis, diuretics, and bedrest have given way to neurohormonal blockade and physical rehabilitation.

  • Evolution of heart failure management: Miles to go
    James B. Young, MD
    Cleveland Clinic Journal of Medicine October 2016, 83 (10) 766-768; DOI: https://doi.org/10.3949/ccjm.83a.16043

    Despite progress, too many patients still suffer, too many die too young, and the costs are still too great.

Pages